- ICH GCP
- US Clinical Trials Registry
- Klinisk forsøg NCT07650539
Respiratory OBservation Using Ultra-Sensitive nanoTechnology (ROBUST)
Respiratory Observation Using Ultra-Sensitive Nanotechnology
The Problem - About one in three patients get even more sick while they are in hospital. This often happens because of chest infections, sepsis (very serious infection), or heart problems. These illnesses can make it hard to breathe. They are even more dangerous when patients already have breathing problems.
Nurses and doctors need to spot when someone is getting worse as early as possible, so they can help them. For example, giving medicines quickly for sepsis can save lives. Sometimes it's hard to tell when someone is getting worse. Sometimes it's noticed too late. This can be very dangerous. In 2023, nearly 8,000 people died because their illness wasn't spotted quickly enough.
Even if patients don't die, they might need longer in hospital and more care. This costs the NHS a lot more money. It also means fewer beds for other patients. Finding better ways to spot these problems early is an important goal.
The Opportunity - Research shows checking patients more often helps spot problems early. Nurses do many routine checks. These include blood pressure, temperature, heart rate and oxygen levels.
Nurses also check the breathing rate (the number of breaths per minute). Breathing rate is the best way to tell if someone is getting sicker. But it is also the hardest to measure properly. The machines we have don't do it well. So, nurses stand by the patient and count how fast they are breathing. This takes time and can be wrong if the patient talks or moves. Sometimes, it's not done at all.
The Need - Breathing rate is very useful. But we don't have good tools to measure it easily. We need something simple and accurate. It should also be comfortable for patients and fit into normal hospital care.
Our New Idea - RespiraFibre - We've made a new device called RespiraFibre. It's a tiny, smart sensor. It attaches to the oxygen masks or tubes that patients already wear. It can tell how the patient is breathing. If something is wrong, it sends a warning to the nurse or doctor.
In this project, we will:
- Work with patients to make sure the RespiraFibre is comfortable.
- Make sure hospital staff find it easy to use.
- Test how accurate it is.
- Try it out on real hospital wards.
- Get it ready to use in hospitals across the country.
The Impact - We want to treat patients fast if they get sick. To do this, we need early warnings if things are getting worse. This will lead to better care, fewer deaths, and lower costs for the NHS. Our work with RespiraFibre will help make this happen.
Studieoversigt
Status
Betingelser
Intervention / Behandling
Detaljeret beskrivelse
Clinical study to assess the function of a novel nanotechnology breathing monitor. It will involve a validation study and a feasibility study of the technology.
- Validation Study - participants who have had surgery and will be admitted to the post-operative recovery department will be invited to take part. These patients receive capnography RR monitoring as standard in a high dependency area and therefore are the ideal group for validation of our technology. We will recruit participants who are undergoing elective surgery therefore will be able to identify them in advance from surgical lists and start the consenting process before admission to hospital. UCLH is a busy surgical centre so recruitment of 48 participants is achievable within 6 months.
- Feasibility study - we will focus monitoring on select wards to concentrate equipment and test ability to monitor multiple participants in the same area simultaneously. The primary focus will be recruitment of participants who have undergone major surgery (defined as expected length of stay >2days) who are recovering on the surgical and post-anaesthetic wards. This group have significant risk of deterioration, mostly require oxygen and are a large group at UCLH. We will focus on elective surgery participants again so we are able to start the consenting process prior to admission. A secondary group of patients who require oxygen due to non-surgical illnesses, such as pneumonia, will also be recruited on the medical wards, to test feasibility in another patient group who will potentially benefit in the future.
Undersøgelsestype
Tilmelding (Anslået)
Fase
- Ikke anvendelig
Kontakter og lokationer
Studiekontakt
- Navn: Robert Tidswell, MBChB PhD
- Telefonnummer: 004420 3456 7890
- E-mail: robert.tidswell@nhs.net
Studiesteder
-
-
-
London, Det Forenede Kongerige
- University College London Hospital
-
Kontakt:
- Robert Tidswell, MBChB PhD
- Telefonnummer: 004420 3456 7890
- E-mail: robert.tidswell@nhs.net
-
-
Deltagelseskriterier
Berettigelseskriterier
Aldre berettiget til at studere
- Voksen
- Ældre voksen
Tager imod sunde frivillige
Beskrivelse
Inclusion Criteria:
- Have capacity to consent to the study
- Undergoing surgery or receiving oxygen therapy
Exclusion Criteria:
- Inability to wear the monitor as designed
Studieplan
Hvordan er undersøgelsen tilrettelagt?
Design detaljer
- Primært formål: Enhedens gennemførlighed
- Tildeling: Ikke-randomiseret
- Interventionel model: Enkelt gruppeopgave
- Maskning: Ingen (Åben etiket)
Våben og indgreb
Deltagergruppe / Arm |
Intervention / Behandling |
|---|---|
|
Aktiv komparator: Validation arm - comparison to capnography
Our monitor will be compared to the gold standard for respiratory rate monitoring, capnography.
It will also be compared to direct expert manual respiratory rate assessment performed by the research team for added validation and to recognise that capnography is not infallible.
|
Patented wireless nanotechnology breathing monitor integrated into oxygen delivery devices to provide continuous respiratory monitoring.
|
|
Aktiv komparator: Feasibility study
We will observe use of our monitor in its planned ultimate environment - hospital wards.
We will assess function and monitoring capability and compare it to standard of care.
|
Patented wireless nanotechnology breathing monitor integrated into oxygen delivery devices to provide continuous respiratory monitoring.
|
Hvad måler undersøgelsen?
Primære resultatmål
Resultatmål |
Foranstaltningsbeskrivelse |
Tidsramme |
|---|---|---|
|
Validation of respiratory rate measurement against capnography
Tidsramme: within 6 months
|
Comparison of respiratory rate captured by experiemental device against that captured by capnography
|
within 6 months
|
|
Demonstrate successful function on hospital wards
Tidsramme: within 30 months
|
Demonstration of continuous respiratory rate monitoring in patients on hospital wards with comparison to usual care
|
within 30 months
|
Samarbejdspartnere og efterforskere
Sponsor
Efterforskere
- Ledende efterforsker: Robert Tidswell, MBChB PhD, University College London Hospitals
Datoer for undersøgelser
Studer store datoer
Studiestart (Anslået)
Primær færdiggørelse (Anslået)
Studieafslutning (Anslået)
Datoer for studieregistrering
Først indsendt
Først indsendt, der opfyldte QC-kriterier
Først opslået (Faktiske)
Opdateringer af undersøgelsesjournaler
Sidste opdatering sendt (Faktiske)
Sidste opdatering indsendt, der opfyldte kvalitetskontrolkriterier
Sidst verificeret
Mere information
Begreber relateret til denne undersøgelse
Nøgleord
Andre undersøgelses-id-numre
- 180997
Plan for individuelle deltagerdata (IPD)
Planlægger du at dele individuelle deltagerdata (IPD)?
Lægemiddel- og udstyrsoplysninger, undersøgelsesdokumenter
Studerer et amerikansk FDA-reguleret lægemiddelprodukt
Studerer et amerikansk FDA-reguleret enhedsprodukt
Disse oplysninger blev hentet direkte fra webstedet clinicaltrials.gov uden ændringer. Hvis du har nogen anmodninger om at ændre, fjerne eller opdatere dine undersøgelsesoplysninger, bedes du kontakte register@clinicaltrials.gov. Så snart en ændring er implementeret på clinicaltrials.gov, vil denne også blive opdateret automatisk på vores hjemmeside .
Kliniske forsøg med Respiratorisk overvågning
-
Assistance Publique - Hôpitaux de ParisAfsluttetUnits Continuous Monitoring (USC)Frankrig
-
University of Colorado, DenverNational Institute of Allergy and Infectious Diseases (NIAID); San Francisco...AfsluttetPrEP Adherence MonitoringForenede Stater
-
Rutgers, The State University of New JerseyAktiv, ikke rekrutterendePrEP Adherence MonitoringForenede Stater
-
Radboud University Medical CenterRekrutteringPædiatrisk anæstesi | Anæstesi | Nociceptiv smerte | Nociception MonitoringHolland
-
Stanford UniversityWork of Breathing Study GroupAfsluttetAstma | Copd | Respirationsindsats | Kontaktløs Vital Sign MonitoringForenede Stater
-
Fondazione ICONARekrutteringForbered | HIV | STI | HIV -1 infektion | STI forebyggelse | PrEP Adherence MonitoringItalien
-
Rise Therapeutics LLCIkke rekrutterer endnuAcute respiratory distress syndrom
-
PT. Prodia Stem Cell IndonesiaRumah Sakit Pusat Angkatan Darat Gatot SoebrotoRekrutteringAcute respiratory distress syndromIndonesien
-
Fondazione IRCCS Ca' Granda, Ospedale Maggiore...Ikke rekrutterer endnu
-
Changchun Tuohua Pharmaceutical Co., Ltd.RekrutteringAcute respiratory distress syndromKina
Kliniske forsøg med Nanotechnology respiratory monitor
-
Neil FinerAfsluttet
-
Tufts Medical CenterAfsluttetFedme | Obstruktiv søvnapnøForenede Stater
-
Yonsei UniversityAfsluttetProstatakræft | BlærekræftKorea, Republikken
-
Bin CaoBioMérieuxUkendt
-
University of LjubljanaScience and Research Centre KoperAfsluttetFysisk kondition | Fysisk undersøgelse | Aerob kapacitet | Cardio respiratorisk fitness | KampberedskabSlovenien
-
University of Mississippi Medical CenterAfsluttetLungeventilation | KapnografiForenede Stater
-
Weill Medical College of Cornell UniversityWeill Cornell Medical College in QatarTrukket tilbage
-
Andrew MeltzerBioMérieuxAfsluttetAkut luftvejsinfektion | Virusinfektion | Infektion i øvre respForenede Stater
-
Aptitude Medical SystemsIkke rekrutterer endnuInfluenza A | Rhinovirus | RSV | Influenza B | Respiratorisk Synctial Virus | COVID-19Forenede Stater
-
Guy's and St Thomas' NHS Foundation TrustPhilips HealthcareAfsluttet